Paper Review Records
All Paper Review Records
18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
36
days
Uncovering non-thrombotic roles of platelets in sepsis pathophysiology
Authors
Ema Hashiguchi; Takashi ItoShow moreShow less
Affiliations
1. Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan; 2. Department of Hematology and Immunology, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanShow moreShow less
22
days
Decitabine and azacitidine exert multifaceted effects beyond DNA hypomethylation in myeloid neoplasms
Authors
Tomohiro Yabushita; Susumu GoyamaShow moreShow less
Affiliations
1. International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan; 2. Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 3. Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, JapanShow moreShow less
99
days
Current perspectives on high-risk genomic profiles in chronic myeloid leukemia: from bench to clinical practice
Authors
Mohamed Isam Sharif; Agustina Maria Perusini; Hassan Sibai; Dennis Dong Hwan KimShow moreShow less
Affiliations
1. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; 2. Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, CanadaShow moreShow less
98
days
TP53 mutations and IGHV in naïve chronic lymphocytic leukemia: retrospective analysis of data from a Spanish collaborative network
Authors
María José Terol; Alicia Serrano; Blanca Ferrer-Lores; Francesc Bosch; Marcos González; Marta Crespo; Miguel Alcoceba; Azahara Fuentes; Felipe Javier Chaves; Miguel VillanuevaShow moreShow less
Affiliations
1. Department of Hematology, University Clinic Hospital of Valencia, INCLIVA (Health Research Institute), University of Valencia, Valencia, Spain; 2. Spanish CLL Study Group (GELLC), Madrid, Spain; 3. Hematology Service, Vall d’Hebron University Hospital, Barcelona, Spain; 4. Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC (CB16/12/00233) and Cancer Research Center -IBMCC (USAL-CSIC), Salamanca, Spain; 5. Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; 6. Experimental Hematology, Hebron Institute of Oncology (VHIO), Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Hebron Barcelona Hospital Campus, Barcelona, Spain; 7. Johnson and Johnson, Madrid, SpainShow moreShow less
97
days
Temporal trends in transfusion-transmitted cytomegalovirus infection among cytomegalovirus-seronegative HSCT recipients
Authors
Kimikazu Yakushijin; Takahiro Fukuda; Masao Ogata; Sachiko Seo; Ryu Yanagisawa; Michiko Kajiwara; Naoyuki Uchida; Youko Suehiro; Noriko Doki; Yoshinobu Kanda; Masatsugu Tanaka; Mineo Kurokawa; Daiichiro Hasegawa; Motoshi Ichikawa; Nobuhiro Tsukada; Yoshiyuki Takahashi; Satoshi Yoshihara; Satoshi Okada; Shinichi Ito; Shingo Yano; Makoto Onizuka; Fumihiko Ishimaru; Yoshiko Atsuta; Hideki NakasoneShow moreShow less
Affiliations
1. Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan; 2. Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; 3. Department of Hematology, Oita University Hospital, Yufu, Japan; 4. Division of Hematology, Department of Internal Medicine, Tokyo Women’s Medical University, Tokyo, Japan; 5. Division of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan; 6. Center for Transfusion Medicine and Cell Therapy, Institute of Science Tokyo Hospital, Tokyo, Japan; 7. Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL, Tokyo, Japan; 8. Department of Hematology and Cell Therapy, NHO Kyushu Cancer Center, Fukuoka, Japan; 9. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; 10. Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; 11. Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan; 12. Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan; 13. Department of Hematology and Oncology, Center of Childhood Cancer, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan; 14. Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan; 15. Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan; 16. Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan; 17. Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan; 18. Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan; 19. Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan; 20. Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan; 21. Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan; 22. Japanese Red Cross Blood Service Headquarters, Tokyo, Japan; 23. Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; 24. Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; 25. Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, JapanShow moreShow less
40
days
Strategies to prevent post-transplant relapse in acute myeloid leukemia and myelodysplastic syndromes
Authors
Yuho NajimaShow moreShow less
Affiliations
1. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, JapanShow moreShow less
FAQ
How long does INTERNATIONAL JOURNAL OF HEMATOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 18 complete review records for INTERNATIONAL JOURNAL OF HEMATOLOGY. The fastest paper went from submission to acceptance in 16 days (Recent advances in the pathophysiology and treatment of GVHD, received 2026-04-05, accepted 2026-04-21); the slowest took 205 days. The average is 83.7 days and the median is 70.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
